NCT05689229View on ClinicalTrials.gov

Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

November 28, 2021

Study Completion Date

December 12, 2021

Conditions

Secondary Bacterial Infection in COVID-19 Patients

Interventions

DRUG

Colistin

COVID-19 patients with secondary gram-negative bacterial infections receive colistin IV or aerosolized

Trial Locations (1)

13556

University Hospital, Banī Suwayf

All Listed Sponsors

lead

Beni-Suef University

OTHER

NCT05689229 - Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter